Augmenting antidepressants with deep transcranial magnetic stimulation (DTMS) in treatment-resistant major depression

References

• Allan C, Kalu UG, Sexton CE, Ebmeier KP. 2012. Transcranial stimulation in depression. Br J Psychiatry 200:10–11.
   PubMed Web of Science ®Google Scholar
• Baeken C, Marinazzo D, Wu GR, Van Schuerbeek P, De Mey J, Marchetti I, et al. 2014. Accelerated HF-rTMS in treatment-resistant unipolar depression: insights from subgenual anterior cingulate functional connectivity. World J Biol Psychiatry 15:286–297.
   Google Scholar
• Beck AT, Epstein N, Brown G, Steer RA. 1988. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 56:893–897.
   PubMed Web of Science ®Google Scholar
• Beck AT, Kovacs M, Weissman A. 1979. Assessment of suicidal intention: the Scale for Suicide Ideation. J Consult Clin Psychol 47:343–352.
   PubMed Web of Science ®Google Scholar
• Berlim MT, Fleck MP, Turecki G. 2008. Current trends in the assessment and somatic treatment of resistant/refractory major depression: an overview. Ann Med 40:149–159.
   PubMed Web of Science ®Google Scholar
• Berlim MT, Pargendler J, Brenner J, Fleck MP. 2007. Significant improvement in the quality of life of Brazilian depressed outpatients 12 weeks following the start of antidepressants. Psychiatry Res 153:253–259.
   PubMed Web of Science ®Google Scholar
• Berlim MT, Turecki G. 2006. Definition, assessment and staging of treatment resistant/refractory major depression: a review of current concepts and methods. Can J Psychiatry 51:875–882.
   Google Scholar
• Berlim MT, Van den Eynde F, Daskalakis ZJ. 2013. High frequency repetitive transcranial magnetic stimulation (rTMS) accelerates and enhances the clinical response to antidepressants in major depression: A meta-analysis of randomized, double-blind and sham-controlled trials. J Clin Psychiatry 74:e122–129.
   PubMed Web of Science ®Google Scholar
• Berlim MT, Van den Eynde F, Perdomo ST, Daskalakis ZJ. 2014. Response, remission and dropout rates following high frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: a systematic review and meta-analysis of randomized, double-blind and sham-controlled trials. Psychol Med 44:225–239.
   PubMed Web of Science ®Google Scholar
• Bersani FS, Minichino A, Enticott PG, Mazzarini L, Khan N, Antonacci G, et al. 2013. Deep transcranial magnetic stimulation as a treatment for psychiatric disorders: a comprehensive review. Eur Psychiatry 28:30–39.
   PubMed Web of Science ®Google Scholar
• Brunoni AR, Fregni F. 2011. Clinical trial design in non-invasive brain stimulation psychiatric research. Int J Methods Psychiatr Res 20:e19–30.
   PubMed Web of Science ®Google Scholar
• Caliyurt O, Guducu F. 2005. Partial sleep deprivation therapy combined with sertraline induces more rapid improvements in quality of life items in major depressive disorder. J Affect Disord 88:75–78.
   PubMed Web of Science ®Google Scholar
• Carpenter LL, Janicak PG, Aaronson ST, Boyadjis T, Brock DG, Cook IA, et al. 2012. Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice. Depress Anxiety 29:587–596.
   PubMed Web of Science ®Google Scholar
• Connolly KR, Helmer A, Cristancho MA, Cristancho P, O’Reardon JP. 2012. Effectiveness of transcranial magnetic stimulation in clinical practice post-FDA approval in the United States: results observed with the first 100 consecutive cases of depression at an academic medical center. J Clin Psychiatry 73:e567–573.
   PubMedGoogle Scholar
• Daskalakis ZJ, Levinson AJ, Fitzgerald PB. 2008. Repetitive transcranial magnetic stimulation for major depressive disorder: a review. Can J Psychiatry 53:555–566.
   PubMed Web of Science ®Google Scholar
• Demyttenaere K, Andersen HF, Reines EH. 2008. Impact of escitalopram treatment on Quality of Life Enjoyment and Satisfaction Questionnaire scores in major depressive disorder and generalized anxiety disorder. Int Clin Psychopharmacol 23:276–286.
   PubMedGoogle Scholar
• Demyttenaere K, Fruyt JD, Huygens R. 2003. Measuring quality of life in depression. Curr Opin Psychiatry 15:89–92.
   Google Scholar
• Deng ZD, Lisanby SH, Peterchev AV. 2013. Electric field depth-focality tradeoff in transcranial magnetic stimulation: simulation comparison of 50 coil designs. Brain Stimul 6:1–13.
   PubMed Web of Science ®Google Scholar
• Dunner DL, Rush AJ, Russell JM, Burke M, Woodard S, Wingard P, et al. 2006. Prospective, long-term, multicenter study of the naturalistic outcomes of patients with treatment-resistant depression. J Clin Psychiatry 67:688–695.
   PubMed Web of Science ®Google Scholar
• Fava M. 2003. Diagnosis and definition of treatment-resistant depression. Biol Psychiatry 53:649–659.
   PubMed Web of Science ®Google Scholar
• Fekadu A, Wooderson SC, Markopoulo K, Donaldson C, Papadopoulos A, Cleare AJ. 2009. What happens to patients with treatment-resistant depression? A systematic review of medium to long term outcome studies. J Affect Disord 116:4–11.
   PubMed Web of Science ®Google Scholar
• Fekadu A, Wooderson SC, Markopoulou K, Cleare AJ. 2009. The Maudsley Staging Method for treatment-resistant depression: prediction of longer-term outcome and persistence of symptoms. J Clin Psychiatry 70:952–957.
   PubMed Web of Science ®Google Scholar
• Fournier JC, DeRubeis RJ, Hollon SD, Dimidjian S, Amsterdam JD, Shelton RC, et al. 2010. Antidepressant drug effects and depression severity: a patient-level meta-analysis. J Am Med Assoc 303:47–53.
   PubMed Web of Science ®Google Scholar
• Fregni F, Pascual-Leone A. 2007. Technology insight: noninvasive brain stimulation in neurology-perspectives on the therapeutic potential of rTMS and tDCS. Nat Clin Pract Neurol 3: 383–393.
   PubMedGoogle Scholar
• Gershon AA, Dannon PN, Grunhaus L. 2003. Transcranial magnetic stimulation in the treatment of depression. Am J Psychiatry 160:835–845.
   PubMed Web of Science ®Google Scholar
• Greden JF. 2001. The burden of disease for treatment-resistant depression. J Clin Psychiatry 62(Suppl 16):26–31.
   PubMedGoogle Scholar
• Hamilton M. 1959. The assessment of anxiety states by rating. Br J Med Psychol 32:50–55.
   PubMed Web of Science ®Google Scholar
• Hamilton M. 1960. A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62.
   PubMed Web of Science ®Google Scholar
• Harel EV, Rabany L, Deutsch L, Bloch Y, Zangen A, Levkovitz Y. 2012. H-coil repetitive transcranial magnetic stimulation for treatment resistant major depressive disorder: an 18-week continuation safety and feasibility study. World J Biol Psychiatry 15:298–306.
   Google Scholar
• Holtzheimer PE 3rd, McDonald WM, Mufti M, Kelley ME, Quinn S, Corso G, et al. 2010. Accelerated repetitive transcranial magnetic stimulation for treatment-resistant depression. Depress Anxiety 27:960–963.
   PubMed Web of Science ®Google Scholar
• Isserles M, Rosenberg O, Dannon P, Levkovitz Y, Kotler M, Deutsch F, et al. 2011. Cognitive-emotional reactivation during deep transcranial magnetic stimulation over the prefrontal cortex of depressive patients affects antidepressant outcome. J Affect Disord 128:235–242.
   PubMed Web of Science ®Google Scholar
• Kennedy SH, Eisfeld BS, Cooke RG. 2001. Quality of life: an important dimension in assessing the treatment of depression? J Psychiatry Neurosci 26(Suppl):S23–28.
   Google Scholar
• Kupfer DJ, Frank E, Phillips ML. 2012. Major depressive disorder: new clinical, neurobiological, and treatment perspectives. Lancet 379:1045–1055.
   PubMed Web of Science ®Google Scholar
• Lam RW, Chan P, Wilkins-Ho M, Yatham LN. 2008. Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and metaanalysis. Can J Psychiatry 53:621–631.
   PubMed Web of Science ®Google Scholar
• Levkovitz Y, Harel EV, Roth Y, Braw Y, Most D, Katz LN, et al. 2010. Deep transcranial magnetic stimulation over the prefrontal cortex: Evaluation of antidepressant and cognitive effects in depressive patients. Brain Stimulation 4:188–200.
   Google Scholar
• Levkovitz Y, Roth Y, Harel EV, Braw Y, Sheer A, Zangen A. 2007. A randomized controlled feasibility and safety study of deep transcranial magnetic stimulation. Clin Neurophysiol 118: 2730–2744.
   PubMed Web of Science ®Google Scholar
• Levkovitz Y, Sheer A, Harel EV, Katz LN, Most D, Zangen A, et al. 2011. Differential effects of deep TMS of the prefrontal cortex on apathy and depression. Brain Stimul 4:266–274.
   PubMed Web of Science ®Google Scholar
• Lisanby SH, Husain MM, Rosenquist PB, Maixner D, Gutierrez R, Krystal A, et al. 2009. Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial. Neuropsychopharmacology 34:522–534.
   PubMed Web of Science ®Google Scholar
• Loo CK, Mitchell PB. 2005. A review of the efficacy of transcranial magnetic stimulation (TMS) treatment for depression, and current and future strategies to optimize efficacy. J Affect Disord 88:255–267.
   PubMed Web of Science ®Google Scholar
• Mishory A, Molnar C, Koola J, Li X, Kozel FA, Myrick H, et al. 2004. The maximum-likelihood strategy for determining transcranial magnetic stimulation motor threshold, using parameter estimation by sequential testing is faster than conventional methods with similar precision. J ECT 20:160–165.
   PubMed Web of Science ®Google Scholar
• Mitchell PB, Loo CK. 2006. Transcranial magnetic stimulation for depression. Aust NZ J Psychiatry 40:406–413.
   PubMed Web of Science ®Google Scholar
• O’Reardon JP, Solvason HB, Janicak PG, Sampson S, Isenberg KE, Nahas Z, et al. 2007. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry 62:1208–1216.
   PubMed Web of Science ®Google Scholar
• Padberg F, Moller HJ. 2003. Repetitive transcranial magnetic stimulation: does it have potential in the treatment of depression? CNS Drugs 17:383–403.
   PubMed Web of Science ®Google Scholar
• Papakostas GI, Petersen T, Mahal Y, Mischoulon D, Nierenberg AA, Fava M. 2004. Quality of life assessments in major depressive disorder: a review of the literature. Gen Hosp Psychiatry 26:13–17.
   PubMed Web of Science ®Google Scholar
• Pridmore S, Fernandes Filho JA, Nahas Z, Liberatos C, George MS. 1998. Motor threshold in transcranial magnetic stimulation: a comparison of a neurophysiological method and a visualization of movement method. J ECT 14:25–27.
   PubMed Web of Science ®Google Scholar
• Rosenberg O, Shoenfeld N, Zangen A, Kotler M, Dannon PN. 2010a. Deep TMS in a resistant major depressive disorder: a brief report. Depress Anxiety 27:465–469.
   PubMed Web of Science ®Google Scholar
• Rosenberg O, Zangen A, Stryjer R, Kotler M, Dannon PN. 2010b. Response to deep TMS in depressive patients with previous electroconvulsive treatment. Brain Stimul 3:211–217.
   PubMed Web of Science ®Google Scholar
• Rosenberg O, Isserles M, Levkovitz Y, Kotler M, Zangen A, Dannon PN. 2011. Effectiveness of a second deep TMS in depression: a brief report. Prog Neuropsychopharmacol Biol Psychiatry 35:1041–1044.
   PubMed Web of Science ®Google Scholar
• Roth Y, Amir A, Levkovitz Y, Zangen A. 2007. Three-dimensional distribution of the electric field induced in the brain by transcranial magnetic stimulation using figure-8 and deep H-coils. J Clin Neurophysiol 24:31–38.
   PubMed Web of Science ®Google Scholar
• Roth Y, Pell GS, Chistyakov AV, Sinai A, Zangen A, Zaaroor M. 2014. Motor cortex activation by H-coil and figure-8 coil at different depths. Combined motor threshold and electric field distribution study. Clin Neurophysiol 125:336–343.
   Google Scholar
• Roth Y, Zangen A, Hallett M. 2002. A coil design for transcranial magnetic stimulation of deep brain regions. J Clin Neurophysiol 19:361–370.
   PubMed Web of Science ®Google Scholar
• Sackeim HA. 2001. The definition and meaning of treatment-resistant depression. J Clin Psychiatry 62(Suppl 16):10–17.
   PubMedGoogle Scholar
• Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. 1998. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59(Suppl 20):22–33; quiz 34–57.
   PubMed Web of Science ®Google Scholar
• Skevington SM. 2002. Advancing cross-cultural research on quality of life: observations drawn from the WHOQOL development. World Health Organisation Quality of Life Assessment. Qual Life Res 11:135–144.
   Google Scholar
• Skevington SM, Lotfy M, O’Connell KA. 2004. The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group. Qual Life Res 13:299–310.
   PubMed Web of Science ®Google Scholar
• Skevington SM, Wright A. 2001. Changes in the quality of life of patients receiving antidepressant medication in primary care: validation of the WHOQOL-100. Br J Psychiatry 178: 261–267.
   PubMed Web of Science ®Google Scholar
• Slotema CW, Blom JD, Hoek HW, Sommer IE. 2010. Should we expand the toolbox of psychiatric treatment methods to include Repetitive Transcranial Magnetic Stimulation (rTMS)? A meta-analysis of the efficacy of rTMS in psychiatric disorders. J Clin Psychiatry 71:873–884.
   PubMed Web of Science ®Google Scholar
• Thase ME. 2001. The need for clinically relevant research on treatment-resistant depression. J Clin Psychiatry 62: 221–224.
   PubMed Web of Science ®Google Scholar
• Trivedi MH, Rush AJ, Ibrahim HM, Carmody TJ, Biggs MM, Suppes T, et al. 2004. The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychol Med 34:73–82.
   PubMed Web of Science ®Google Scholar
• Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, et al. 2006. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 163:28–40.
   PubMed Web of Science ®Google Scholar
• Vieta E, Colom F. 2011. Therapeutic options in treatment- resistant depression. Ann Med 43:512–530.
   PubMed Web of Science ®Google Scholar
• Wassermann EM, Zimmermann T. 2012. Transcranial magnetic brain stimulation: therapeutic promises and scientific gaps. Pharmacol Ther 133:98–107.
   PubMed Web of Science ®Google Scholar
• Wisniewski SR, Rush AJ, Balasubramani GK, Trivedi MH, Nierenberg AA. 2006. Self-rated global measure of the frequency, intensity, and burden of side effects. J Psychiatr Pract 12:71–79.
   PubMedGoogle Scholar
• Zangen A, Roth Y, Voller B, Hallett M. 2005. Transcranial magnetic stimulation of deep brain regions: evidence for efficacy of the H-coil. Clin Neurophysiol 116:775–779.
   PubMed Web of Science ®Google Scholar